Start-up firm finds salt-free sibutramine

Published: 2006-09-21 06:56:00

Updated: 2006-09-21 06:56:00

CTC Bio, a Korean venture start-up, said it has acquired a new patent for salt-free sibutramine it claims can demonstrate an equal absorption rate compared with an original anti-obesity agent.

We will carry out more clinical tests in order to improve its efficiency in the battle against obesit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK